Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole with Neoadjuvant Chemotherapy in Breast Cancer
NCT04874935Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jun 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole in breast cancer, sponsored by Tanta University. Started Jun 2021; status: completed.
02
Drugs
lansoprazole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04874935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874935.